Rosaria J. Ferreira

Rosaria J. Ferreira

Auto-generated profile, based on publicly available information

Rosaria J. Ferreira

Center for Congenital Heart Diseases, Department of Paediatric Cardiology, Beatrix Children’s Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Chest
Verified
Journal Article
Open access
MPMark-Jan Ploegstra
Mark-Jan Ploegstra
RFRosaria J. Ferreira
Rosaria J. Ferreira
CLChantal Lokhorst
Chantal Lokhorst
EGEva Gouwy
Eva Gouwy
SSSuzanne S.J. Schwartz
Suzanne S.J. Schwartz
RBRolf M.F. Berger
Rolf M.F. Berger
Pediatric pulmonary hypertension (PH) is a severe incurable disease with poor prognosis. In pediatric PH, trial design is hampered by the absence of age-appropriate trial endpoints. This study evaluated physical activity (PA) measured by hip-anchored accelerometry as a potential trial endpoint in pediatric PH. Is PA-accelerometry associated with disease severity, and based on this association, what minimal important differences (MIDs) correspond to meaningful changes in disease severity in pediatric PH? Accelerometer outputs from 54 children with hemodynamically confirmed PH were analyzed. Univariable linear regression and mixed effect models were respectively used for cross sectional and longitudinal analyses 1) to evaluate the association between Z-scores of PA-accelerometry counts per minute (CPM-Z) and of % of time spent in moderate or vigorous physical activity (%MVPA-Z) and disease severity indices 6-minute walk-distance Z-scores (6MWD-Z), World Health Organization functional class (WHO-FC), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and tricuspid annular plane systolic excursion Z-scores (TAPSE-Z) and 2) to perform anchor-based MID estimations for CPM-Z and %MVPA-Z, using defined clinical functional impairment levels (6MWD-Z and WHO-FC) as reference anchors. When assessing the association between disease severity and PA-accelerometry cross-sectionally, we found significant associations between CPM-Z and WHO-FC, 6MWD-Z and NT-proBNP. %MVPA-Z was significantly associated with WHO-FC and 6MWD-Z. In longitudinal analysis, these associations were confirmed throughout the disease course. MID estimations, expressed in Z-score units, resulted in mean MIDs of 0.3-0.4 CPM-Z when anchored to 6MWD-Z, 0.7 CPM-Z when anchored to WHO-FC, 0.4-0.5 %MVPA-Z when anchored to 6MWD-Z and 0.5-0.6 %MVPA-Z when anchored to WHO-FC. This study underscores the robust relationship between PA-accelerometry and disease severity in children with PH and fills a critical gap in pediatric PH trial design and evaluation of treatment efficacy by providing anchor-based MID-estimates for hip-anchored PA-accelerometry.

14 June 2025 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
HCHung Chu
Hung Chu
RFRosaria J. Ferreira
Rosaria J. Ferreira
CLChantal Lokhorst
Chantal Lokhorst
JDJohannes Menno Douwes
Johannes Menno Douwes
MHMeindina G. Haarman
Meindina G. Haarman
MPMark-Jan Ploegstra
Mark-Jan Ploegstra
Purpose: Pulmonary arterial hypertension (PAH) significantly affects the pulmonary vasculature, requiring accurate estimation of mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance index (PVRi). Although cardiac catheterization is the gold standard for these measurements, it poses risks, especially in children. This pilot study explored how machine learning (ML) can predict pulmonary hemodynamics from non-invasive cardiac magnetic resonance (CMR) cine images in pediatric PAH patients. Methods: A retrospective analysis of 40 CMR studies from children with PAH using a four-fold stratified group cross-validation was conducted. The endpoints were severity profiles of mPAP and PVRi, categorised as ‘low’, ‘high’, and ‘extreme’. Deep learning (DL) and traditional ML models were optimized through hyperparameter tuning. Receiver operating characteristic curves and area under the curve (AUC) were used as the primary evaluation metrics. Results: DL models utilizing CMR cine imaging showed the best potential for predicting mPAP and PVRi severity profiles on test folds (AUCmPAP=0.82 and AUCPVRi=0.73). True positive rates (TPR) for predicting low, high, and extreme mPAP were 5/10, 11/16, and 11/14, respectively. TPR for predicting low, high, and extreme PVRi were 5/13, 14/15, and 7/12, respectively. Optimal DL models only used spatial patterns from consecutive CMR cine frames to maximize prediction performance. Conclusion: This exploratory pilot study demonstrates the potential of DL leveraging CMR imaging for non-invasive prediction of mPAP and PVRi in pediatric PAH. While preliminary, these findings may lay the groundwork for future advancements in CMR imaging in pediatric PAH, offering a pathway to safer disease monitoring and reduced reliance on invasive cardiac catheterization.